Manager TitleAgeSince
Chief Executive Officer 49 31/05/2025
Director of Finance/CFO 61 31/05/2025
Sales & Marketing 53 01/01/2024
Director TitleAgeSince
Director/Board Member 62 01/01/2020
Chairman 42 01/06/2025
Director/Board Member 75 01/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 7L
+0.84%-3.53%-26.95%+0.67% 17TCr
-0.07%-2.41%-8.89%+10.23% 11TCr
+0.90%+2.11%-24.36%+0.79% 10TCr
-1.24%-1.31%-48.43%-13.54% 7.48TCr
-0.24%-0.26%-0.87%+71.72% 5.91TCr
-0.86%+4.49%+17.49%+57.78% 5.18TCr
-0.71%-1.36%-7.41%-31.61% 4.85TCr
+0.12%+0.97%-16.40%+18.55% 4.08TCr
-1.01%-2.41%+29.18%-8.51% 3.25TCr
Average -3.59%-0.48%-9.63%+11.79% 7.67TCr
Weighted average by Cap. +0.10%-1.13%-15.78%+9.41%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock